Stoke Therapeutics (STOK) EBIT Margin (QoQ) (2022 - 2026)
Stoke Therapeutics (STOK) EBIT Margin (QoQ) (2022 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Stoke Therapeutics |
1.95 Bn |
1.95 Bn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
352,467.00 |
| Dec 31, 2025 |
-397,694.00 |
| Sep 30, 2025 |
-20,771.00 |
| Jun 30, 2025 |
-26,774.00 |
| Mar 31, 2025 |
13,053.00 |
| Dec 31, 2024 |
55,268.00 |
| Sep 30, 2024 |
-569.00 |
| Jun 30, 2024 |
6,559.00 |
| Mar 31, 2024 |
38,293.00 |
| Dec 31, 2023 |
-23,261.00 |
| Sep 30, 2023 |
51,739.00 |
| Jun 30, 2023 |
-86,144.00 |
| Mar 31, 2023 |
35,235.00 |
| Dec 31, 2022 |
10,295.00 |
| Sep 30, 2022 |
-15,341.00 |
| Jun 30, 2022 |
4,538.00 |
